Literature DB >> 12697649

Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.

Katherine S Barker1, Margaret M Pearson, P David Rogers.   

Abstract

OBJECTIVE: An isolate of S. cerevisiae with reduced susceptibility to fluconazole and itraconazole was developed in the laboratory and used to identify genes that are differentially expressed in association with this phenotype.
METHODS: S. cerevisiae strain ATCC 9763 was passaged in increasing concentrations of itraconazole. Itraconazole and fluconazole MICs for the initial isolate (9763S) were 2 and 16 mg/L and for the final isolate (9763I) were 16 and > or =64 mg/L, respectively. Duplicate sets of total RNA from 9763S and 9763I were isolated and hybridized to Affymetrix S98 yeast arrays. To validate results, six differentially expressed genes were further examined by RT-PCR.
RESULTS: Of the nearly 6400 open reading frames represented on the array, a total of 116 genes (1.8%) were found to be differentially expressed. Cell wall maintenance genes TIR4 and CCW12, sterol metabolism gene UPC2, small molecule transport genes AUS1 and YHK8, and stress response gene CUP1-1 were expressed at a level at least 2.5-fold higher than the expression level found in 9763S. Eleven energy generation genes, ionic homeostasis genes FRE1, FRE2 and FRE4, and sterol metabolism genes ERG8 and ERG13 were expressed at least 2.5-fold lower than the expression level found in 9763S.
CONCLUSIONS: Several genes found to be differentially expressed in this study have been shown previously to be differentially expressed in the fungal response to azole treatment. In addition, the potential role of AUS1 and/or YHK8 as mediators of drug efflux is intriguing and warrants further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697649     DOI: 10.1093/jac/dkg217

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

Review 1.  Metabolic engineering in the -omics era: elucidating and modulating regulatory networks.

Authors:  Goutham N Vemuri; Aristos A Aristidou
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

2.  The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.

Authors:  Ann R Holmes; Mikhail V Keniya; Irena Ivnitski-Steele; Brian C Monk; Erwin Lamping; Larry A Sklar; Richard D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

3.  UPC2A is required for high-level azole antifungal resistance in Candida glabrata.

Authors:  Sarah G Whaley; Kelly E Caudle; John-Paul Vermitsky; Sean G Chadwick; Geoffrey Toner; Katherine S Barker; Scott E Gygax; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  Gene exchange between two divergent species of the fungal human pathogen, Coccidioides.

Authors:  Colin S Maxwell; Kathleen Mattox; David A Turissini; Marcus M Teixeira; Bridget M Barker; Daniel R Matute
Journal:  Evolution       Date:  2018-12-04       Impact factor: 3.694

5.  Genomic landscape of the DHA1 family in Candida auris and mapping substrate repertoire of CauMdr1.

Authors:  Rosy Khatoon; Suman Sharma; Poonam Vishwakarma; Amandeep Saini; Parth Aggarwal; Andrew M Lynn; Amresh Prakash; Rajendra Prasad; Atanu Banerjee
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

6.  Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering.

Authors:  Dwight Kuo; Kai Tan; Guy Zinman; Timothy Ravasi; Ziv Bar-Joseph; Trey Ideker
Journal:  Genome Biol       Date:  2010-07-23       Impact factor: 13.583

7.  A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides.

Authors:  Belén López-García; Mónica Gandía; Alberto Muñoz; Lourdes Carmona; Jose F Marcos
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

8.  Role of ferric reductases in iron acquisition and virulence in the fungal pathogen Cryptococcus neoformans.

Authors:  Sanjay Saikia; Debora Oliveira; Guanggan Hu; James Kronstad
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

9.  Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.

Authors:  Neena Jain; Radames J B Cordero; Arturo Casadevall; Bettina C Fries
Journal:  Mol Microbiol       Date:  2013-04-09       Impact factor: 3.501

10.  Microarray karyotyping of commercial wine yeast strains reveals shared, as well as unique, genomic signatures.

Authors:  Barbara Dunn; R Paul Levine; Gavin Sherlock
Journal:  BMC Genomics       Date:  2005-04-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.